Roth Capital Adding Macrogenics To "Focus List", Maintains Buy Rating With A PT Of $45
December 15, 2014 at 05:49 AM EST
Roth Capital maintains a Buy on Macrogenics and raises the PT from $32.00 to $45.00
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.